Two-year treatment of growth hormone (GH) receptor deficiency with recombinant insulin-like growth factor I in 22 children: Comparison of two dosage levels and to GH-treated GH deficiency

Journal of Clinical Endocrinology and Metabolism

Volumn 82, Issue 2, 1997, Pages 629-633

  Guevara Aguirre, Jaime ^a,d   Rosenbloom, Arlan L ^b   Vasconez, Oswaldo ^a   Martinez, Victor ^a   Gargosky, Sharron E ^c   Allen, Linda ^b   Rosenfeld, Ron G ^c  

^a Inst Endocrinol   (Ecuador)

^b UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

^c OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^d Institute of Endocrinology IEMIR   (Ecuador)

Author keywords

[No Author keywords available]

Indexed keywords

GROWTH HORMONE; GROWTH HORMONE RECEPTOR; RECOMBINANT GROWTH HORMONE; RECOMBINANT SOMATOMEDIN C; SOMATOMEDIN BINDING PROTEIN 3; SOMATOMEDIN C;

ADOLESCENT; ARTICLE; BODY MASS; CHILD; CHILD GROWTH; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; FEMALE; FOLLOW UP; GROWTH HORMONE DEFICIENCY; HORMONAL THERAPY; HUMAN; LARON SYNDROME; MALE; PRESCHOOL CHILD; PRIORITY JOURNAL; SCHOOL CHILD; SUBCUTANEOUS DRUG ADMINISTRATION;

ADOLESCENT; CHILD; CHILD, PRESCHOOL; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; HUMANS; INSULIN-LIKE GROWTH FACTOR BINDING PROTEIN 3; INSULIN-LIKE GROWTH FACTOR I; MALE; RECEPTORS, SOMATOTROPIN; RECOMBINANT PROTEINS;

EID: 0031015949     PISSN: 0021972X     EISSN: None     Source Type: Journal    
DOI: 10.1210/jc.82.2.629     Document Type: Article

References (19)

1. Rosenfeld RG, Rosenbloom AL, Guevara-Aguirre J. 1994 Growth hormone (GH) insensitivity due to primary GH receptor deficiency. Endocr Rev. 15:369-390.
2. Rosenbloom AL, Guevara-Aguirre J. 1994 Bienvenidos a mi tierra de soledad: from poetry to molecular biology in southern Ecuador. J Clin Endocrinol Metab. 79:695-702.
3. Guevara-Aguirre J, Vasconez O, Martinez V, et al. 1995 A randomized double-blind, placebo-controlled trial of safety and efficacy of recombinant insulin-like growth factor-I in children with growth hormone receptor deficiency. J Clin Endocrinol Metab. 80:1393-1398.
4. Daughaday WH, Rotwein P. 1989 Insulin-like growth factors I and II. Peptide, messenger ribonucleic acid and gene structures, serum, and tissue concentrations. Endocr Rev, 10:68-91.
5. Rosenbloom AL, Guevara-Aguirre J, Martinez AL, et al. 1995 Comparison of GH replacement therapy in GH deficiency (GHD) to IGF-I replacement in GH receptor deficiency (GHRD): evidence for a direct effect of GH on growth. Pediatr Res. 37:97A.
6. Berg MA, Guevara-Aguirre J, Rosenbloom AL, Rosenfeld RG, Francke U. 1992 Mutation creating a new splice site in the growth hormone receptor genes of 37 Ecuadorian patients with Laron syndrome. Hum Mutat. 1:24-34.
7. Greulich WW, Pyle SI. 1959 Radiographic atlas of skeletal development of the hand and wrist, 2nd ed. Stanford: Stanford University Press.
8. Genentech National Cooperative Growth Study. 1994 Cumulative data review. Summary report 18.
9. National Center for Health Statistics, Hamil PVV. 1977 NCHS growth curves for children birth-18 years: United States. Vital and health statistics, series 11, no. 165. Washington DC: Government Printing Office; DHEW publication no. (PHS) 78-1650.
10. Gargosky SE, Pham HM, Wilson KF, Lin F, Guidice LC, Rosenfeld RG. 1992 Measurement and characterization of insulin-like growth factor binding protein-3 in human biological fluids: discrepancies between radioimmunoassay and ligand blotting. Endocrinology. 131:3051-3060.
11. Rosenbloom AL, Guevara-Aguirre J, Rosenfeld RG, Pollock BH. 1994 Growth in growth hormone insensitivity. Trends Endocrinol Metab. 5:296-303.
12. Klinger B, Laron Z. 1995 Three year IGF-I treatment of children with Laron syndrome. J Pediatr Endocrinol Metab. 8:149-158.
13. Ranke MB, Savage MO, Chatelain PG, et al. 1995 Insulin-like growth factor I improves height in growth hormone insensitivity: two years' results. Horm Res. 44:253-264.
14. Backeljauw PF, Underwood LE, The GHIS Collaborative Group. 1996 Prolonged treatment with recombinant insulin-like growth factor-I in children with growth hormone insensitivity syndrome - a clinical research center study. J Clin Endocrinol Metab. 81:3312-3317.
15. Vaccarello MA, Diamond Jr FB, Guevara-Aguirre J, et al. 1993 Hormonal and metabolic effects and pharmacokinetics of recombinant human insulin-like growth factor-I in growth hormone receptor deficiency/Laron syndrome. J Clin Endocrinol Metab. 77:273-280.
16. Thorén MC, Wivall-Helleryd IL, Blum WF, Hall KE. 1994 Effects of repeated subcutaneous administration of recombinant human insulin-like growth factor I in adults with growth hormone deficiency. Eur J Endocrinol. 131:33-40.
17. Blum WF, Ranke MB, Savage MO, Hall K, Kabi Pharmacia Study Group. 1992 Insulin-like growth factors and their binding proteins in patients with growth hormone receptor deficiency: suggestions for new diagnostic criteria. Acta Paediatr. 383(Suppl):125-126.
18. Boulware SC, Rennert NJ, Busby WH, Tamborlane WV, Sherwin RS. Differential responsiveness of IGF binding proteins (IGFBP)-1 and 2 to IGF-I and insulin (INS) infusions in humans (Abstract 1600). Proc of the 75th Annual Meeting of The Endocrine Society, 1993.
19. Woods KA, Camacho-Hübner C, Savage MO, Clark AJL. 1996 Intrauterine growth retardation and postnatal growth failure associated with deletion of the insulin-like growth factor-I gene. N. Engl J Med. 335:1363-1367.